NDC 60505-6245

Cefepime

Cefepime

Cefepime is a Intramuscular; Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp.. The primary component is Cefepime Hydrochloride.

Product ID60505-6245_3206f96c-8101-459c-9da2-0f35046e7501
NDC60505-6245
Product TypeHuman Prescription Drug
Proprietary NameCefepime
Generic NameCefepime
Dosage FormInjection, Powder, For Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2022-09-01
Marketing CategoryANDA /
Application NumberANDA203704
Labeler NameApotex Corp.
Substance NameCEFEPIME HYDROCHLORIDE
Active Ingredient Strength1 g/1
Pharm ClassesCephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 60505-6245-4

10 VIAL, SINGLE-DOSE in 1 CARTON (60505-6245-4) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
Marketing Start Date2022-09-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Cefepime" or generic name "Cefepime"

NDCBrand NameGeneric Name
0338-1301Cefepimecefepime
0409-9566CefepimeCefepime
0409-9735CefepimeCefepime
25021-121cefepimecefepime hydrochloride
25021-122cefepimecefepime hydrochloride
44567-130CefepimeCefepime
44567-131CefepimeCefepime
44567-240CefepimeCefepime
44567-241CefepimeCefepime
71288-008CefepimeCefepime
71288-009CefepimeCefepime
60505-6147CefepimeCefepime
60505-6144CefepimeCefepime
60505-6146CefepimeCefepime
60505-6145CefepimeCefepime
60505-6030CefepimeCefepime
60505-6031CefepimeCefepime
63323-340CefepimeCefepime
63323-326CefepimeCefepime
66794-210CefepimeCefepime
66288-8100CEFEPIMECEFEPIME
67184-1003CefepimeCefepime
67184-1004CefepimeCefepime
66794-209CefepimeCefepime
67184-1002CefepimeCefepime
71288-021CefepimeCefepime
71288-020CefepimeCefepime
0409-0217MAXIPIMECefepime
0409-0218MAXIPIMECefepime
0409-0219MAXIPIMECefepime
0409-0220MAXIPIMECefepime
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.